TIAA Trust, National Association’s Vertex Pharmaceuticals VRTX Stock Holding History

TIAA Trust, National Association’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$497	Sell	1 -11	-92%	-$4.88K	﹤0.01%	341
2026 Q1	$5.36K	Sell	12 -5,117	-100%	-$2.39M	﹤0.01%	371
2025 Q4	$2.33M	Sell	5,129 -153	-3%	-$65.9K	0.01%	292
2025 Q3	$2.07M	Sell	5,282 -121	-2%	-$50.6K	0.01%	305
2025 Q2	$2.41M	Sell	5,403 -520	-9%	-$240K	0.01%	282
2025 Q1	$2.87M	Buy	5,923 +160	+3%	+$74.6K	0.01%	262
2024 Q4	$2.32M	Buy	5,763 +131	+2%	+$60.7K	0.01%	283
2024 Q3	$2.62M	Buy	5,632 +43	+0.8%	+$20.7K	0.01%	270
2024 Q2	$2.62M	Buy	5,589 +241	+5%	+$105K	0.01%	255
2024 Q1	$2.24M	Buy	5,348 +26	+0.5%	+$11K	0.01%	273
2023 Q4	$2.17M	Sell	5,322 -20	-0.4%	-$7.39K	0.01%	261
2023 Q3	$1.86M	Buy	+5,342	New	+$1.87M	0.01%	263

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

TIAA Trust, National Association's VRTX Position: Q2 2026 in Review

TIAA Trust, National Association reduced its Vertex Pharmaceuticals (VRTX) stake by 92% in Q2 2026, selling an estimated $4.88K and leaving 1 share worth $497. The position accounts for ﹤0.01% of the portfolio, ranked #341.

TIAA Trust, National Association first reported a position in VRTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.87M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

TIAA Trust, National Association held 1 share of Vertex Pharmaceuticals worth $497 as of Q2 2026.
TIAA Trust, National Association sold 11 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.88K.
Vertex Pharmaceuticals made up ﹤0.01% of TIAA Trust, National Association's portfolio in Q2 2026, its #341 holding.
TIAA Trust, National Association first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
TIAA Trust, National Association's Vertex Pharmaceuticals position peaked at $2.87M in Q1 2025.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on TIAA Trust, National Association's 13F filing for Q2 2026, filed 10 Aug 2026.